FOI2026/00993 – Information on a specific adverse event report
Published 12 August 2026
© Crown copyright 2026
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/vmd-foieir-requests-may-2026/foi202600993-information-on-a-specific-adverse-event-report
1. Your request
Please provide all information you have as to how my adverse event report reference number 01642/24 has been considered, recorded, and used by the VMD in its pharmacovigilance in respect of Librela.
2. Our reply
Information on how the VMD assesses, records, and uses adverse event reports for pharmacovigilance purposes is publicly available at: How the VMD monitors the safety of animal medicines - GOV.UK
This guidance provides comprehensive details on the processes applied to all adverse event reports received by the VMD.